XENETIC BIOSCIENCES, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$3M
Cost of Revenue
—
Gross Profit
—
R&D
$3M
D&A
—
Operating Income
$-3M
EBITDA
$-3M
Interest Expense
—
Interest Income
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income
$-3M
Gross Margin
—
Operating Margin
-95.2%
Net Margin
-90.1%
Effective Tax Rate
—
Revenue YoY Variation
19.0%
Income YoY Variation
32.6%